Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma

Journal of Urology

Volumn 193, Issue 6, 2015, Pages 1905-1910

  Iacovelli, Roberto ^a   Farcomeni, Alessio ^c   Sternberg, Cora N ^d   Cartenì, Giacomo ^f   Milella, Michele ^e   Santoni, Matteo ^h   Cerbone, Linda ^d   Di Lorenzo, Giuseppe ^g   Verzoni, Elena ^a   Ortega, Cinzia ⁱ   Sabbatini, Roberto ^j   Ricotta, Riccardo ^b   Messina, Caterina ^k   Lorusso, Vito ^l   Atzori, Francesco ^m   De Vincenzo, Fabio ⁿ   Sacco, Cosimo ^o   Boccardo, Francesco ^p   Valduga, Francesco ^q   Massari, Francesco ^r   Baldazzi, Valentina ^s   Cinieri, Saverio ^t   Mosca, Alessandra ^u   Maria Ruggeri, Enzo ^v   Berruti, Alfredo ^w   Procopio, Giuseppe ^a   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^f CARDARELLI HOSPITAL   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

ⁱ CANDIOLO CANCER INSTITUTE   (Italy)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k OSPEDALI RIUNITI   (Italy)

^l NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^m DEPARTMENT OF RADIOLOGY   (Italy)

ⁿ HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^o SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^p UNIVERSITY OF GENOA   (Italy)

^q SANTA CHIARA HOSPITAL   (Italy)

^r UNIVERSITY OF VERONA   (Italy)

^s SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^t A Perrino Hospital   (Italy)

^u University Hospital Maggiore della Carita   (Italy)

^v BELCOLLE HOSPITAL   (Italy)

^w UNIVERSITY OF BRESCIA   (Italy)

more..

Author keywords

carcinoma; kidney; neoplasm metastasis; nomograms; prognosis; renal cell

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; EXTERNAL VALIDITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ITALY; KIDNEY METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; NEPHRECTOMY; NEUTROPHIL COUNT; NOMOGRAM; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL TIME; CARCINOMA, RENAL CELL; CLINICAL TRIAL; MORTALITY; MULTICENTER STUDY; PROGNOSIS; SURVIVAL RATE;

CARCINOMA, RENAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NOMOGRAMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84929269618     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.11.092     Document Type: Article

References (17)

1. S.K. Pa, and R.A. Figlin Targeted therapies for renal cell carcinoma: understanding their impact on survival Target Oncol 5 2010 131
2. R.J. Motzer, T.E. Hutson, and L. McCann Overall survival in renal-cell carcinoma with pazopanib versus sunitinib N Engl J Med 370 2014 1769
3. R. Iacovelli, D. Alesini, and A. Palazzo Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials Cancer Treat Rev 40 2014 271
4. R.J. Motzer, M. Mazumdar, and J. Bacik Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma J Clin Oncol 17 1999 2530
5. T.M. Mekhail, R.M. Abou-Jawde, and G. Boumerhi Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma J Clin Oncol 23 2005 832
6. D.Y. Heng, W. Xie, and M.M. Regan Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 2009 5794
7. T.K. Choueiri, Z.D. Lim, and M.S. Hirsch Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma Cancer 116 2010 5219
8. J.J. Ko, W. Xie, and D.Y. Heng The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT) J Clin Oncol 32 suppl. 2014 abstract 398
9. M.J. Pencina, R.B. D'Agostino, and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11
10. D.Y. Heng, W. Xie, and M.M. Regan External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study Lancet Oncol 14 2013 141
11. R. Iacovelli, G. Cartenì, and C.N. Sternberg Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort Eur J Cancer 49 2013 2134
12. A. Levy, J. Menard, and L. Albiges Second line treatment of metastatic renal cell carcinoma: the Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients Eur J Cancer 49 2013 1898
13. J.J. Ko, T.K. Choueiri, and B.I. Rini First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC Br J Cancer 110 2014 1917
14. R.J. Motzer, C. Porta, and N.J. Vogelzang Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial Lancet Oncol 15 2014 286
15. M. Bianchi, M. Sun, and C. Jeldres Distribution of metastatic sites in renal cell carcinoma: a population-based analysis Ann Oncol 23 2012 973
16. S. Négrier, B. Escudier, and F. Gomez Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie Ann Oncol 13 2002 1460
17. R.R. McKay, N. Kroeger, and W. Xie Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy Eur Urol 65 2014 577